Page 1 of 1

● Chapter 31-Case Study 20-year-old male, Michael, with ALL is receiving chemotherapy. biM 2900 Two weeks after his seco

Posted: Mon Jul 11, 2022 2:19 pm
by answerhappygod
Chapter 31 Case Study 20 Year Old Male Michael With All Is Receiving Chemotherapy Bim 2900 Two Weeks After His Seco 1
Chapter 31 Case Study 20 Year Old Male Michael With All Is Receiving Chemotherapy Bim 2900 Two Weeks After His Seco 1 (50.33 KiB) Viewed 55 times
Chapter 31 Case Study 20 Year Old Male Michael With All Is Receiving Chemotherapy Bim 2900 Two Weeks After His Seco 2
Chapter 31 Case Study 20 Year Old Male Michael With All Is Receiving Chemotherapy Bim 2900 Two Weeks After His Seco 2 (49.44 KiB) Viewed 55 times
● Chapter 31-Case Study 20-year-old male, Michael, with ALL is receiving chemotherapy. biM 2900 Two weeks after his second treatment, he notices small reddish-purple spots on his lower legs and ankles. CBC • WBC 2 x 10⁹/L Hb 9 g/dL Plts 19 x 10⁹/L↓↓ ● ● 4.5-11 * 109/2 ~12-14 gldL 150-400 +10%/L
129 Chapter 31-Case Study Question 4: What is the most likely cause of Michael's pancytopenia? ● ● Question 5: Why would the administration of growth factors such as erythropoietin (EPO) and TPO be considered in this case? HEMOSTASIS LECTURE 1 129